Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / American Depositary Shares, each representing 1 Ordinary Shares
-
Shares outstanding
-
100M
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
7.04M
-
Shares change
-
-258K
-
Total reported value, excl. options
-
$222M
-
Value change
-
-$5.95M
-
Put/Call ratio
-
2.12
-
Number of buys
-
38
-
Number of sells
-
-22
-
Price
-
$31.51
Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q1 2018
78 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q1 2018.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.04M shares
of 100M outstanding shares and own 7.02% of the company stock.
Largest 10 shareholders include FMR LLC (3.59M shares), CREDIT SUISSE AG/ (450K shares), SPHERA FUNDS MANAGEMENT LTD. (339K shares), NEXTHERA CAPITAL LP (333K shares), PERCEPTIVE ADVISORS LLC (300K shares), Tekla Capital Management LLC (283K shares), MORGAN STANLEY (253K shares), LAZARD ASSET MANAGEMENT LLC (153K shares), ASCEND CAPITAL, LLC (124K shares), and BlackRock Inc. (123K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.